Skip to Content

NHIA submits comments on home health rule

NHIA submits comments on home health rule

WASHINGTON – The National Home Infusion Association has submitted comments to a final rule saying it is disappointed that CMS has not revisited the Medicare Part B home infusion benefit. 

The CY 2022 Home Health Rule outlines proposed coverage and policy changes for home infusion and other post-acute services.   

The NHIA’s key concern with the current benefit: the requirement that a nurse or other health care professional be present in the patient’s home for the home infusion provider to be paid for those services. That has led to low participation in the benefit by home infusion providers, the association says. 

In its comments, NHIA requested that CMS modify the definition of infusion drug administration calendar day to remove the in-person requirement and ensure that home infusion providers are reimbursed for each day the patient receives an infusion medication, consistent with the intent of the 21st Century Cures Act and with practices in the commercial market.  

NHIA also expressed concern over the lack of comprehensive standards for ensuring the quality and safety of home infusion and urged CMS to require standards for compounding and other components of the service found in the commercial sector.


To comment on this post, please log in to your account or set up an account now.